Home
Conditions
Gram-Negative Bacterial Infections

Clinical trial condition

Gram-Negative Bacterial Infections

Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.

1,462 public trials 132 recruiting studies

Refine in advanced search Browse all conditions

Gram-Negative Bacterial Infections trial results

Completed

Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea

NCT02350907

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Communicable Diseases, +9 more
Locations: University Hospital of Bern Bern, Switzerland

Ambulatorium Kanonengasse Zurich, Switzerland

Checkpoint Zurich Zurich, Switzerland

View Trial Details

Completed

Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants

NCT01616459

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations: GSK Investigational Site Benešov, Czechia

GSK Investigational Site Děčín, Czechia

GSK Investigational Site Domažlice, Czechia

GSK Investigational Site Jindřichův Hradec, Czechia

View all 42 locations

View Trial Details

Completed

Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.

NCT00775138

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bronchial Diseases, +7 more
Locations: Washington D.C., District of Columbia, United States

Philadelphia, Pennsylvania, United States

Sofia, Bulgaria

Athens, Greece

View all 18 locations

View Trial Details

Completed

Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts

NCT02864433

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Cholera, +7 more
Locations: Hopital St Nicholas Saint-Marc, Haiti

View Trial Details

Completed

South Australian Meningococcal B Vaccine Herd Immunity Study

NCT03089086

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: Vaccinology & Immunology Research Trials Unit North Adelaide, South Australia, Australia

View Trial Details

Completed

Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine

NCT02639351

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Berlin, Germany

View Trial Details

Completed

A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study

NCT03089879

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +8 more
Locations: GSK Investigational Site Paris, France

View Trial Details

Completed

Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

NCT02112890

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +15 more
Locations: GSK Investigational Site Cuernavaca, Morelos, Mexico

View Trial Details

Completed

Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents

NCT02212457

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Jonesboro, Arkansas, United States

GSK Investigational Site Hialeah, Florida, United States

GSK Investigational Site Melbourne, Florida, United States

GSK Investigational Site Augusta, Kansas, United States

View all 32 locations

View Trial Details

Completed

Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations

NCT02446691

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Ansan-si, South Korea

GSK Investigational Site Incheon, South Korea

GSK Investigational Site Jeonju, South Korea

GSK Investigational Site Seongnam-si, South Korea

View Trial Details

Gram-Negative Bacterial Infections

Gram-Negative Bacterial Infections trial results

Related conditions